Eman M.E. Dokla
- Co-authors
- Khaled A. M. AbouzidRabah A.T. SeryaAmal Kamal Abdel‐AzizChing‐Shiun ChenMaha NasrMohamed N. SeleemMartin J. McPhillieNader S. Abutaleb
- Topics
- Acute Myeloid Leukemia Research (4 papers)Protein Degradation and Inhibitors (4 papers)Chronic Myeloid Leukemia Treatments (4 papers)
- Partner nations
- EgyptUnited StatesTaiwan
In The Last Decade
Eman M.E. Dokla
22 papers receiving 326 citations
Peers
Comparison fields: 5 of 67
- Molecular Biology 138
- Organic Chemistry 131
- Oncology 41
- Infectious Diseases 36
- Molecular Medicine 29
Countries citing papers authored by Eman M.E. Dokla
This map shows the geographic impact of Eman M.E. Dokla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eman M.E. Dokla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eman M.E. Dokla more than expected).
Fields of papers citing papers by Eman M.E. Dokla
This network shows the impact of papers produced by Eman M.E. Dokla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eman M.E. Dokla. The network helps show where Eman M.E. Dokla may publish in the future.
Co-authorship network of co-authors of Eman M.E. Dokla
This figure shows the co-authorship network connecting the top 25 collaborators of Eman M.E. Dokla. A scholar is included among the top collaborators of Eman M.E. Dokla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eman M.E. Dokla. Eman M.E. Dokla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 2 | |
| 3 | 3 | |
| 4 | 1 | |
| 5 | 8 | |
| 6 | 12 | |
| 7 | 7 | |
| 8 | 9 | |
| 9 | 21 | |
| 10 | 5 | |
| 11 | 18 | |
| 12 | 16 | |
| 13 | 94 | |
| 14 | 11 | |
| 15 | 39 | |
| 16 | 56 | |
| 17 | 8 | |
| 18 | 8 | |
| 19 | 2 | |
| 20 | 6 |
About Eman M.E. Dokla
Eman M.E. Dokla is a scholar working on Molecular Medicine, Hematology and Cell Biology, having authored 22 papers that have together received 334 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (4 papers), Protein Degradation and Inhibitors (4 papers) and Chronic Myeloid Leukemia Treatments (4 papers). The work is most often cited by research in Molecular Medicine (29 citations), Organic Chemistry (131 citations) and Toxicology (14 citations). Eman M.E. Dokla has collaborated with scholars based in Egypt, United States and Taiwan. Frequent co-authors include Khaled A. M. Abouzid, Rabah A.T. Serya, Amal Kamal Abdel‐Aziz, Ching‐Shiun Chen, Maha Nasr, Mohamed N. Seleem, Martin J. McPhillie, Nader S. Abutaleb, Saverio Minucci and Christian D. Klein. Their work appears in journals such as PLoS ONE, Biochemical Pharmacology and European Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.